Compound information
- Natural Products
- ZC238736
- Molecular Formula
- C20H29N5O5
- Molecular Weight
- 419.216869028 g/mol
- Structure
-
- IUPAC Name
- methyl (2R)-1-[(2R)-2-(benzyloxycarbonylamino)-5-guanidino-pentanoyl]pyrrolidine-2-carboxylate
- InChI
- InChI=1S/C20H29N5O5/c1-29-18(27)16-10-6-12-25(16)17(26)15(9-5-11-23-19(21)22)24-20(28)30-13-14-7-3-2-4-8-14/h2-4,7-8,15-16H,5-6,9-13H2,1H3,(H,24,28)(H4,21,22,23)/t15-,16-/m1/s1
- InChI Key
- SDSIMCZEPCWUQN-HZPDHXFCSA-N
- SMILES
- COC(=O)[C@H]1CCCN1C(=O)[C@@H](CCCNC(=N)N)NC(=O)OCc1ccccc1
- Source
- ZINC000096027881
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 30 | Ring Count | 2 |
Heteroatom Count | 10 | Rotatable Bond Count | 9 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 4 |
Topological Polar Surface Area | 146.84 Å2 | LogP | 0.487 |
LogS | -2.217 | LogD | 0.75 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.032 | Pgp substrate | 0.996 |
HIA | 0.758 | F20 % | 0.949 |
F30 % | 0.001 | Caco-2 | -6.082 |
MDCK | -5.443 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.324 | PPB | 34.24 |
VD | 0.642 | Fu | 0.09 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.0 | CYP1A2 substrate | 0.558 |
CYP2A6 substrate | 0.305 | CYP2B6 substrate | 0.489 |
CYP2C19 inhibitor | 0.066 | CYP2C19 substrate | 0.585 |
CYP2C8 substrate | 0.506 | CYP2C9 inhibitor | 0.116 |
CYP2C9 substrate | 0.869 | CYP2D6 inhibitor | 0.012 |
CYP2D6 substrate | 0.756 | CYP2E1 substrate | 0.345 |
CYP3A4 inhibitor | 0.341 | CYP3A4 substrate | 0.947 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.729 | CL | 3.708 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.11 | Hepatotoxicity | 0.092 |
Mutagenicity | 0.036 | Rat Oral Acute Toxicity | 0.094 |
FDAMDD | 0.309 | Skin Sensitization | 0.002 |
Carcinogenicity | 0.001 | Eye Corrosion | 0.003 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.138 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.613 | IGC50 | 2.281 |
LC50FM | 2.145 | LC50DM | -1.295 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.28 | NR-AR-LBD | 0.245 |
NR-AhR | 0.002 | NR-Aromatase | 0.018 |
NR-ER | 0.257 | NR-ER-LBD | 0.367 |
NR-PPAR-gamma | 0.181 | SR-ARE | 0.137 |
SR-ATAD5 | 0.272 | SR-HSE | 0.123 |
SR-MMP | 0.006 | SR-p53 | 0.046 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.